SynthesisMedicine2016

Increased risk of hemorrhage in metastatic colorectal cancer patients treated with bevacizumab: An updated meta-analysis of 12 randomized controlled trials.

Xiaoqiang Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.